Skip to content
Screener

Aktis Oncology, Inc. AKTS Q1 2026 earnings

Reported May 11, 2026 · Before market open

Revenue$3.2MBeat by $997.0K
EPS-$0.38Miss by $0.07
Revenue estimate$2.2M
EPS estimate-$0.31

Next report

Date not yet announced

FAQ

When did Aktis Oncology, Inc. report Q1 2026 earnings?
Aktis Oncology, Inc. (AKTS) reported Q1 2026 earnings on May 11, 2026 before market open.
What were Aktis Oncology, Inc.'s Q1 2026 revenue and EPS?
Aktis Oncology, Inc. reported revenue of $3.2M and eps of $-0.38 for Q1 2026.
Did Aktis Oncology, Inc. beat estimates in Q1 2026?
Revenue beat the consensus estimate of $2.2M by $997.0K. EPS missed the consensus estimate of $-0.31 by $0.07.
Where can I find Aktis Oncology, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-216716) and the 10-Q periodic report (0001193125-26-216749) directly on SEC EDGAR. The filing index links above go to sec.gov.